Quantitative analysis of microbicide concentrations in fluids, gels and tissues using confocal raman spectroscopy

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Chuchuen, Oranat ^a   Henderson, Marcus H ^a   Sykes, Craig ^b   Kim, Min Sung ^a   Kashuba, Angela D M ^b,c   Katz, David F ^a,d  

^a Duke University   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANIMAL; FEMALE; RAMAN SPECTROMETRY; SWINE;

ANIMALS; ANTI-HIV AGENTS; FEMALE; SPECTRUM ANALYSIS, RAMAN; SWINE;

EID: 84893535639     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085124     Document Type: Article

References (82)

1. Joint United Nations Programme on HIV/AIDS (2012) Global report: UNAIDS report on the global AIDS epidemic 2012. UNAIDS.
2. Cutler B, Justman J (2008) Vaginal microbicides and the prevention of HIV transmission. Lancet Infect Dis 8: 685-697. doi:10.1016/S1473-3099(08)70254-8. PubMed: 18992405.
3. Kiser PF, Johnson TJ, Clark JT (2012) State of the art in intravaginal ring technology for topical prophylaxis of HIV infection. AIDS Rev 14: 62-77. PubMed: 22297505.
4. Karim QA, Karim SSA, Frohlich JA, Grobler AC, Baxter C et al. (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329: 1168-1174. doi:10.1126/science.1193748. PubMed: 20643915.
5. Centre for the AIDS Programme of Research in South Africa (2007) Safety and effectiveness study of a candidate vaginal microbicide for prevention of HIV. Available: http://clinicaltrials.gov/show/NCT00441298. Accessed 9 January 2013
6. NIAID (2008) Safety and effectiveness of tenofovir 1% gel, tenofovir disproxil fumarate, and emtricitabine/tenofovir disoproxil fumarate tablets in preventing HIV in women. Available. Available: http://clinicaltrials.gov/show/ NCT00705679. Accessed 9 January 2013
7. Conrad (2011) Safety and effectiveness of tenofovir gel in the prevention of human immunodeficiency virus (HIV-1) infection in women and the effects of tenofovir gel on the incidence of herpes simplex virus (HSV-2) infection. Available: http://clinicaltrials.gov/show/NCT01386294. Accessed 9 January 2013
8. Robbins BL, Srinivas RV, Kim C, Bischofberger N, Fridland A (1998) Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2- phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA. Antimicrob Agents Chemother 42: 612-617. PubMed: 9517941. (Pubitemid 28114817)
9. Plosker GL (2013) Emtricitabine/tenofovir disoproxil fumarate: a review of its use in HIV-1 pre-exposure prophylaxis. Drugs, 73: 1-13. PubMed: 23329465.
10. Rohan LC, Moncla BJ, Kunjara Na Ayudhya RP, Cost M, Huang Y et al. (2010) In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. PLOS ONE 5: e9310. doi:10.1371/journal.pone.0009310. PubMed: 20174579.
11. Dezzutti CS, Brown ER, Moncla B, Russo J, Cost M et al. (2012) Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity. PLOS ONE 7: e48328. doi:10.1371/journal.pone.0048328. PubMed: 23144863.
12. Dezzutti CS, Shetler C, Mahalingam A, Ugaonkar SR, Gwozdz G et al. (2012) Safety and efficacy of tenofovir/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention. Antiviral Res 96: 221-225. doi:10.1016/j.antiviral.2012.08.004. PubMed: 22940075.
13. Mahalingam A, Simmons AP, Ugaonkar SR, Watson KM, Dezzutti CS et al. (2011) Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1. Antimicrob Agents Chemother 55: 1650-1660. doi:10.1128/AAC.01368-10. PubMed: 21245437.
14. Nel AM, Coplan P, Smythe SC, McCord K, Mitchnick M et al. (2010) Pharmacokinetic assessment of dapivirine vaginal microbicide gel in healthy, HIV-negative women. AIDS Res Hum Retroviruses 26: 1181-1190. doi:10.1089/aid.2009.0227. PubMed: 20854207.
15. Romano J, Variano B, Coplan P, Van Roey J, Douville K et al. (2009) Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring. AIDS Res Hum Retroviruses 25: 483-488. doi:10.1089/aid.2008.0184. PubMed: 19388819.
16. Choi SO, Rezk N, Kim JS, Kashuba AD (2010) Development of an LCMS method for measuring TNF in human vaginal tissue. J Chromatogr Sci 48: 219-223. doi:10.1093/chromsci/48.3.219. PubMed: 20223089.
17. Das Neves J, Sarmento B, Amiji M, Bahia MF (2012) Development and validation of a HPLC method for the assay of dapivirine in cell-based and tissue permeability experiments. J Chromatogr B Analyt Technol Biomed Life Sci 911: 76-83. doi:10.1016/j.jchromb.2012.10.034. PubMed: 23217310.
18. Gao Y, Katz DF (2013) Multicompartmental pharmacokinetic model of tenofovir delivery by a vaginal gel. PLOS ONE 8: e74404. doi:10.1371/journal. pone.0074404. PubMed: 24040241.
19. Syková E, Nicholson C (2008) Diffusion in brain extracellular space. Physiol Rev 88: 1277-1340. doi:10.1152/physrev.00027.2007. PubMed: 18923183.
20. Franz TJ (1975) Percutaneous absorption. On the relevance of in vitro data. J Invest Dermatol 64: 190-195. doi:10.1111/1523-1747.ep12533356. PubMed: 123263.
21. Bronaugh RL, Stewart RF, Simon M (1986) Methods for in vitro percutaneous absorption studies. VII: Use of excised human skin. J Pharm Sci 75: 1094-1097. doi:10.1002/jps.2600751115. PubMed: 3820104. (Pubitemid 17216557)
22. Grass GM, Sweetana SA (1988) In vitro measurement of gastrointestinal tissue permeability using a new diffusion cell. Pharm Res 5: 372-376. doi:10.1023/A:1015911712079. PubMed: 3244649.
23. Abner SR, Guenthner PC, Guarner J, Hancock KA, Cummins JE et al. (2005) A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection. J Infect Dis 192: 1545-1556. doi:10.1086/462424. PubMed: 16206069. (Pubitemid 41504690)
24. Cummins JE, Guarner J, Flowers L, Guenthner PC, Bartlett J et al. (2007) Preclinical testing of candidate topical microbicides for antihuman immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture. Antimicrob Agents Chemother 51: 1770-1779. doi:10.1128/AAC. 01129-06. PubMed: 17353237. (Pubitemid 46744157)
25. Doncel GF, Clark MR (2010) Preclinical evaluation of anti-HIV microbicide products: new models and biomarkers. Antiviral Res 88: S10-S18. doi:10.1016/j.antiviral.2010.09.018. PubMed: 21109063.
26. Zeng H, Zhao J, Short M, Mclean DI, Lam S, et al. (2008) Raman spectroscopy for in vivo tissue analysis and diagnosis, from instrument development to clinical applications. J Innov Opt Health Sci 1: 95-106.
27. Movasaghi Z, Rehman S, Rehman IU (2007) Raman spectroscopy of biological tissues. Appl Spectrosc Rev 42: 493-541. doi:10.1080/05704920701551530. (Pubitemid 47421526)
28. Chernenko T, Matthäus C, Milane L, Quintero L, Amiji M et al. (2009) Label-free Raman spectral imaging of intracellular delivery and degradation of polymeric nanoparticle systems. ACS Nano 3: 3552-3559. doi:10.1021/nn9010973. PubMed: 19863088.
29. Zhang Y, Hong H, Cai W (2010) Imaging with Raman spectroscopy. Curr Pharm Biotechnol 11: 654-661. doi:10.2174/138920110792246483. PubMed: 20497112.
30. Erckens RJ, March WF, Jongsma FH, Wicksted JP, Hendrikse F et al. (2001) Noninvasive Raman spectroscopic identification of intraocular lens material in the living human eye. J Cataract Refract Surg 27: 1065-1070. doi:10.1016/S0886-3350(00)00828-2. PubMed: 11489577. (Pubitemid 32734156)
31. Tfayli A, Piot O, Pitre F, Manfait M (2007) Follow-up of drug permeation through excised human skin with confocal Raman microspectroscopy. Eur Biophys J 36: 1049-1058. doi:10.1007/s00249-007-0191-x. PubMed: 17565493. (Pubitemid 350045040)
32. Zhang G, Moore DJ, Sloan KB, Flach CR, Mendelsohn R (2007) Imaging the prodrug-to-drug transformation of a 5-fluorouracil derivative in skin by confocal Raman microscopy. J Invest Dermatol 127: 1205-1209. doi:10.1038/sj.jid.5700690. PubMed: 17218938. (Pubitemid 46625154)
33. Chrit L, Hadjur C, Morel S, Sockalingum G, Lebourdon G et al. (2005) In vivo chemical investigation of human skin using a confocal Raman fiber optic microprobe. J Biomed Opt 10: 44007. doi:10.1117/1.2003747. PubMed: 16178641.
34. Khan KM, Krishna H, Majumder SK, Rao KD, Gupta PK (2013) Depthsensitive Raman spectroscopy combined with optical coherence tomography for layered tissue analysis. J Biophotonics: ([MedlinePgn:]) PubMed: 23359612.
35. Bell SE, Dennis AC, Fido LA, Malcolm RK, Sirimuthu NM et al. (2007) Characterization of silicone elastomer vaginal rings containing HIV microbicide TMC120 by Raman spectroscopy. J Pharm Pharmacol 59: 203-207. doi:10.1211/jpp.59.2.0007. PubMed: 17270074. (Pubitemid 46203059)
36. Hendrix CW, Chen BA, Guddera V, Hoesley C, Justman J et al. (2013) MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments. PLOS ONE 8: e55013. doi:10.1371/journal.pone.0055013. PubMed: 23383037.
37. Nel AM, Smythe SC, Habibi S, Kaptur PE, Romano JW (2010) Pharmacokinetics of 2 dapivirine vaginal microbicide gels and their safety vs. hydroxyethyl cellulose-based universal placebo gel. J Acquir Immune Defic Syndr 55: 161-169. doi:10.1097/QAI.0b013e3181e3293a. PubMed: 20574411.
38. Johnson TJ, Gupta KM, Fabian J, Albright TH, Kiser PF (2010) Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. Eur J Pharm Sci 41: 736-736. doi:10.1016/j.ejps.2010.09.010. PubMed: 19958831.
39. International Partnership for Microbicides (2012) Phase 3 safety and effectiveness trial of dapivirine vaginal ring for prevention of HIV-1 in women (ASPIRE). Available: http://clinicaltrials.gov/show/NCT01617096. Accessed 9 January 2013
40. International Partnership for Microbicides (2012) Safety and efficacy trial of a dapivirine Vaginal matrix ring in healthy HIV-negative women. Available: http://clinicaltrials.gov/ct2/show/NCT01539226. Accessed 9 January 2013
41. Watson KM, Yang L, Buckheit RW (2011) Development of dual-acting pyrimidinediones as novel and highly potent topical anti-HIV microbicides. Antimicrob Agents Chemother 55: 5243-5254. doi:10.1128/AAC.05237-11. PubMed: 21896906.
42. Van Der Bijl P, Thompson IO, Squier CA (1997) Comparative permeability of human vaginal and buccal mucosa to water. Eur J Oral Sci 105: 571-575. doi:10.1111/j.1600-0722.1997.tb00219.x. PubMed: 9469607. (Pubitemid 127760549)
43. Shojaei AH (1998) Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci 1: 15-30. PubMed: 10942969.
44. Wertz PW, Swartzendruber DC, Squier CA (1993) Regional variation in the structure and permeability of oral mucosa and skin. Adv Drug Deliv Rev 12: 1-12. doi:10.1016/0169-409X(93)90037-5.
45. Van Eyk AD, Van Der Bijl P (2004) Comparative permeability of various chemical markers through human vaginal and buccal mucosa as well as porcine buccal and mouth floor mucosa. Arch Oral Biol 49: 387-392. doi:10.1016/j. archoralbio.2003.12.002. PubMed: 15041486. (Pubitemid 38431024)
46. Squier CA, Mantz MJ, Schlievert PM, Davis CC (2008) Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. J Pharm Sci 97: 9-21. doi:10.1002/jps.21077. PubMed: 17721937.
47. Williams AC, Barry BW, Edwards HGM (1994) Comparison of fourier-transform Raman-spectra of mammalian and reptilian skin. Analyst 119: 563-566. doi:10.1039/an9941900563. PubMed: 8024120.
48. Franzen L, Mathes C, Hansen S, Windbergs M (2013) Advanced chemical imaging and comparison of human and porcine hair follicles for drug delivery by confocal Raman microscopy. J Biomed Opt 18: 061210. PubMed: 23165762.
49. Surmacki J, Musial J, Kordek R, Abramczyk H (2013) Raman imaging at biological interfaces: applications in breast cancer diagnosis. Mol Cancer 12: 48. doi:10.1186/1476-4598-12-48. PubMed: 23705882.
50. Nicolazzo JA, Reed BL, Finnin BC (2003) The effect of various in vitro conditions on the permeability characteristics of the buccal mucosa. J Pharm Sci 92: 2399-2410. doi:10.1002/jps.10505. PubMed: 14603485. (Pubitemid 37484766)
51. Imbert D, Cullander C (1999) Buccal mucosa in vitro experiments: I. Confocal imaging of vital staining and MTT assays for the determination of tissue viability. J Control Release 58: 39-50. doi:10.1016/S0168-3659(98)00143- 6. PubMed: 10021488. (Pubitemid 29371812)
52. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63. doi:10.1016/0022-1759(83)90303-4. PubMed: 6606682.
53. Supino R (1995) MTT assays. Methods Mol Biol 43: 137-149. PubMed: 7550641.
54. Hershey FB, Cruickshank CN, Mullins LI (1958) The quantitative reduction of 2,3,5-triphenyl tetrazolium chloride by skin in vitro. J Histochem Cytochem 6: 191-196. doi:10.1177/6.3.191. PubMed: 13525694.
55. Slater TF, Sawyer B, Sträuli U (1963) Studies on succinate-tetrazolium reductase systems: III. Points of coupling of four different tetrazolium salts. Biochim Biophys Acta 77: 383-393. doi:10.1016/0006-3002(63)90513-4. PubMed: 14089413.
56. Microbicide Trials Network (2010) Phase 2B safety and effectiveness study of tenofovir 1% gel, tenofovir disoproxil fumarate tablet and emtricitabine/tenofovir disoproxil fumarate tablet for the prevention of HIV infection in women. Available: http://www.mtnstopshiv.org/node/373. Accessed 7 August 2013
57. Tien D, Schnaare RL, Kang F, Cohl G, McCormick TJ et al. (2005) In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials. AIDS Res Hum Retroviruses 21: 845-853. doi:10.1089/aid.2005.21.845. PubMed: 16225411. (Pubitemid 43150316)
58. Schwartz JL, Rountree W, Kashuba AD, Brache V, Creinin MD et al. (2011) A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel. PLOS ONE 6: e25974. doi:10.1371/journal.pone.0025974. PubMed: 22039430.
59. Skoog DA, Leary JJ (1992) Principles of instrumental analysis. Philadelphia: Saunders College Publishing.
60. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310. PubMed: 2868172. (Pubitemid 16134762)
61. Holtz M, Dasgupta PK, Zhang GF (1999) Small-volume Raman spectroscopy with a liquid core waveguide. Anal Chem 71: 2934-2938. doi:10.1021/ac981261i. (Pubitemid 29340488)
62. Keller MJ, Madan RP, Torres NM, Fazzari MJ, Cho S et al. (2011) A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel. PLOS ONE 6: e16475. doi:10.1371/journal.pone.0016475. PubMed: 21283552.
63. Kashuba AD, Abdool Karim SS, Kraft E, White N, Sibeko S, et al. (2010) Do systemic and genital tract tenofovir concentrations predict HIV seroconversion in the CAPRISA 004 tenofovir gel trial? Abstract TUSS0503. XVIII International AIDS Conference. Vienna.
64. US Food and Drug Administration (2001) Guidance for industry: bioanalytical method validation. Available: http://www.fda.gov/downloads/Drugs/ Guidances/ucm070107.pdf. Accessed 2 April 2013
65. Lai BE, Geonnotti AR, DeSoto MG, Montefiori DC, Katz DF (2010) Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro. Antiviral Res 88: 143-151. doi:10.1016/j.antiviral.2010.08.006. PubMed: 20709109.
66. Ng SF, Rouse JJ, Sanderson FD, Meidan V, Eccleston GM (2010) Validation of a static franz diffusion cell system for in vitro permeation studies. AAPS PharmSciTech 11: 1432-1441. doi:10.1208/s12249-010-9522-9. PubMed: 20842539.
67. Cost M, Dezzutti CS, Clark MR, Friend DR, Akil A et al. (2012) Characterization of UC781-tenofovir combination gel products for HIV-1 infection prevention in an ex vivo ectocervical model. Antimicrob Agents Chemother 56: 3058-3066. doi:10.1128/AAC.06284-11. PubMed: 22430977.
68. Everall NJ (2000) Confocal Raman microscopy: why the depth resolution and spatial accuracy can be much worse than you think. Appl Spectrosc 54: 1515-1520. doi:10.1366/0003702001948439.
69. Everall NJ (2000) Modeling and measuring the effect of refraction on the depth resolution of confocal Raman microscopy. Appl Spectrosc 54: 773-782. doi:10.1366/0003702001950382.
70. Bruneel JL, Lassegues JC, Sourisseau C (2002) In-depth analyses by confocal Raman microspectrometry: experimental features and modeling of the refraction effects. J Raman Spectrosc 33: 815-828. doi:10.1002/jrs.915.
71. Xiao CH, Flach CR, Marcott C, Mendelsohn R (2004) Uncertainties in depth determination and comparison of multivariate with univariate analysis in confocal Raman studies of a laminated polymer and skin. Appl Spectrosc 58: 382-389. doi:10.1366/000370204773580202. PubMed: 15104806.
72. Tfayli A, Piot O, Manfait M (2008) Confocal Raman microspectroscopy on excised human skin: uncertainties in depth profiling and mathematical correction applied to dermatological drug permeation. J Biophotonics 1: 140-153. doi:10.1002/jbio.200710004. PubMed: 19343645.
73. Baldwin KJ, Batchelder DN (2001) Confocal Raman microspectroscopy through a planar interface. Appl Spectrosc 55: 517-524. doi:10.1366/0003702011952190. (Pubitemid 32546937)
74. Mathlouthi M, Seuvre AM, Koenig JL (1984) Ft-Ir and laser-Raman spectra of adenine and adenosine. Carbohydr Res 131: 1-15. doi:10.1016/0008-6215(84) 85398-7.
75. Lanir A, Yu NT (1979) A Raman spectroscopic study of the interaction of divalent metal ions with adenine moiety of adenosine 5'-triphosphate. J Biol Chem 254: 5882-5887. PubMed: 447685.
76. Zhelyaskov V, Yue KT (1992) A Raman study of the binding of Fe(III) to ATP and AMP. Biochem J 287: 561-566. PubMed: 1445215.
77. Ramkumaar GR, Srinivasan S, Bhoopathy TJ, Gunasekaran S (2013) Vibrational spectroscopic studies of tenofovir using density functional theory method. J Chem: 2013.
78. Singh JS (2008) FTIR and Raman spectra and fundamental frequencies of biomolecule: 5-methyluracil (thymine). J Mol Struct 876: 127-133. doi:10.1016/j.molstruc.2007.06.014.
79. Dong J, Drohat AC, Stivers JT, Pankiewicz KW, Carey PR (2000) Raman spectroscopy of uracil DNA glycosylase-DNA complexes: insights into DNA damage recognition and catalysis. Biochemistry 39: 13241-13250. doi:10.1021/bi001437m. PubMed: 11052677.
80. Lambert JB, Shurvell HF, Lightner D, Cooks RG (1987) Introduction to organic spectroscopy. New York: Macmillan.
81. 3 complexes (M=Cr, Mo or W): an insight into metal-arene bonding. Appl Organomet Chem 4: 569-580. doi:10.1002/aoc.590040519.
82. Kuwae A, Machida K (1979) Vibrational spectra of benzonitrile-p-d and benzonitrile-d 5 and force-field of benzonitrile. Spectrochim Acta - Journal of Mol Spectroscopy 35: 841-845. doi:10.1016/0584-8539(79)80043-4.